Merit Medical Sys (MMSI) 23.60 $MMSI
Merit Medical to Present at Two Conferences
GlobeNewswire - Mon Aug 01, 8:25AM CDT
Canaccord Genuity - August 11
MMSI: 23.60 (+0.16)
Downgrade Alert for Merit Medical Systems (MMSI)
Comtex SmarTrend(R) - Fri Jul 29, 3:30AM CDT
Merit Medical Systems (NASDAQ:MMSI) was downgraded from Outperform to Market Perform at Barrington today. The stock closed yesterday at $23.47 on volume of 835,000 shares, above average daily volume of 248,000. Potential upside of 13.6% exists for Merit Medical Systems, based on a current level of $23.47 and analysts' average consensus price target of $26.67. The stock should discover initial support at its 200-day moving average (MA) of $20.17 and subsequent support at its 50-day MA of $18.88.
MMSI: 23.60 (+0.16)
Shares of MMSI Up 25.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 28, 1:51PM CDT
SmarTrend identified an Uptrend for Merit Medical Systems (NASDAQ:MMSI) on March 3rd, 2016 at $18.92. In approximately 5 months, Merit Medical Systems has returned 25.79% as of today's recent price of $23.80.
MMSI: 23.60 (+0.16)
Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016
GlobeNewswire - Wed Jul 27, 3:00PM CDT
-- Q2 revenue of $151.1 million ($151.7 million in constant currency), up 9.4% as reported, up 9.9% on a comparable, constant currency basis, over Q2 2015
MMSI: 23.60 (+0.16)
Merit Medical Announces Appointment of New Director
GlobeNewswire - Tue Jul 26, 3:00PM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy, announced today that it has appointed David M. Liu, MD, Fellow of the Royal College of Physicians of Canada (FRCPC), diplomate of the American Board of Radiology, and Fellow of the Society of Interventional Radiology (FSIR), to serve as a director of the Company.
MMSI: 23.60 (+0.16)
Dental Stock Earnings Queued Up for Jul 27: MCK, LH & More
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 7:55AM CDT
Here we take a look at four Dental stocks set to report earnings on Jul 27.
MCK: 192.09 (-2.47), CNMD: 40.17 (-0.47), LH: 139.63 (+0.07), MMSI: 23.60 (+0.16)
Merit Medical Systems to Announce Second Quarter Results on July 27, 2016
GlobeNewswire - Thu Jul 14, 8:00AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the second quarter ended June 30, 2016, after the close of the stock market on Wednesday, July 27, 2016.
MMSI: 23.60 (+0.16)
Merit Medical to Present at UBS Global Healthcare Conference
GlobeNewswire - Thu May 12, 8:00AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the UBS Global Healthcare Conference being held May 23-25 at the Grand Hyatt New York.
MMSI: 23.60 (+0.16)
Merit Medical Appointed Global Distributor for Micro Guide Wire
GlobeNewswire - Tue May 10, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has signed a distribution deal with PIOLAX Medical Devices, Inc. of Yokohama, Japan for a product known in Japan as the Labyrinth Noah(TM) Micro Guide Wire. The deal covers all global markets, with the exception of Japan, and is subject to certain minimum order requirements.
MMSI: 23.60 (+0.16)
Merit Medical meets 1Q profit forecasts
Automated Insights - Thu Apr 28, 6:44PM CDT
SOUTH JORDAN, Utah (AP) _ Merit Medical Systems Inc. (MMSI) on Thursday reported first-quarter profit of $4.4 million.
MMSI: 23.60 (+0.16)
Merit Medical Reports Sales Up 6.6% for the Quarter Ended March 31, 2016
GlobeNewswire - Thu Apr 28, 3:00PM CDT
-- Q1 revenue of $138.1 million ($140.0 million in constant currency), up 6.6% as reported, up 8.0% on a comparable, constant currency basis
MMSI: 23.60 (+0.16)
Merit Medical Systems to Announce First Quarter Results on April 28, 2016
GlobeNewswire - Mon Apr 04, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the first quarter ended March 31, 2016, after the close of the stock market on Thursday, April 28, 2016.
MMSI: 23.60 (+0.16)
Merit Medical Announces 510(k) Clearance for Corvocet(TM) Biopsy System
GlobeNewswire - Mon Mar 28, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it received notification of substantial equivalence from the FDA for the Corvocet(TM) Biopsy System, which is intended for use in obtaining core biopsy samples from the liver, kidney, prostate, breast, lung and various other soft tissue tumors.
MMSI: 23.60 (+0.16)
Merit Medical to Present at Four Conferences
GlobeNewswire - Wed Feb 10, 8:30AM CST
RBC Capital Markets - February 24
MMSI: 23.60 (+0.16)
Global Non-vascular Stents Market 2016-2020 with Boston Scientific, Cook Medical, C.R. Bard & Medtronic Dominating
M2 - Mon Feb 08, 11:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/lhzzfb/global) has announced the addition of the "Global Non-vascular Stents Market 2016-2020" report to their offering. The global non-vascular stents market to grow at a CAGR of 5.24% during the period 2016-2020. Global Non-vascular Stents Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Advances in technology have resulted in the introduction of stents in a wide range of sizes, designs, and materials. A typical gastrointestinal or urologic stent is about 18 cm. There are other micro stents available for different stent applications. The use of biodegradable polymer in non-vascular stents has the advantages of biocompatibility and eliminating the need for stent removal. According to the report, the increased incidence of gastrointestinal disorders such as colon cancer, rectal cancer, and other urological conditions, coupled with the aging population, is driving market growth. Further, the report states that complications associated with non-vascular stents restricts the market growth. To calculate the market size, the report considers the revenue generated from the sales of non-vascular stents, which are segmented as follows: - Gastrointestinal stents - Urological stents - Pulmonary stents Key vendors - Boston Scientific - Cook Medical - C.R. Bard - Medtronic Other prominent vendors - Allium Medical - EFER Endoscopy - Amecath - Applied Medical - BIOTEQ - BVM Medical - Coloplast - ConMed - ELLA-CS - EndoChoice - Hobbs Medical - Merit Endotek - Merit Medical Systems - Novatech - Olympus - Surgimedik - Taewoong Medical - Xlumena For more information visit http://www.researchandmarkets.com/research/lhzzfb/global
BSX: 24.43 (+0.15), MDT: 88.06 (+0.43), MMSI: 23.60 (+0.16)
Merit Medical Systems Down 21.8% Since SmarTrend Downtrend Call (MMSI)
Comtex SmarTrend(R) - Fri Feb 05, 6:07PM CST
SmarTrend identified a Downtrend for Merit Medical Systems (NASDAQ:MMSI) on October 23rd, 2015 at $20.09. In approximately 4 months, Merit Medical Systems has returned 21.75% as of today's recent price of $15.72.
MMSI: 23.60 (+0.16)
Merit Medical Systems to Announce Fourth Quarter and Year End Results on February 22, 2016
GlobeNewswire - Thu Feb 04, 3:00PM CST
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the fourth quarter and year ended December 31, 2015, after the close of the stock market on Monday, February 22, 2016.
MMSI: 23.60 (+0.16)
Merit Medical Acquires the HeRO(R)Graft From CryoLife, Inc.
GlobeNewswire - Thu Feb 04, 10:04AM CST
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, today announced that it has purchased the HeRO(R)Graft device and related assets from CryoLife, Inc.
CRY: 14.32 (-0.25), MMSI: 23.60 (+0.16)
Merit Medical to Present at Two Conferences
GlobeNewswire - Mon Aug 01, 8:25AM CDT
Canaccord Genuity - August 11
MMSI: 23.60 (+0.16)
Downgrade Alert for Merit Medical Systems (MMSI)
Comtex SmarTrend(R) - Fri Jul 29, 3:30AM CDT
Merit Medical Systems (NASDAQ:MMSI) was downgraded from Outperform to Market Perform at Barrington today. The stock closed yesterday at $23.47 on volume of 835,000 shares, above average daily volume of 248,000. Potential upside of 13.6% exists for Merit Medical Systems, based on a current level of $23.47 and analysts' average consensus price target of $26.67. The stock should discover initial support at its 200-day moving average (MA) of $20.17 and subsequent support at its 50-day MA of $18.88.
MMSI: 23.60 (+0.16)
Shares of MMSI Up 25.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 28, 1:51PM CDT
SmarTrend identified an Uptrend for Merit Medical Systems (NASDAQ:MMSI) on March 3rd, 2016 at $18.92. In approximately 5 months, Merit Medical Systems has returned 25.79% as of today's recent price of $23.80.
MMSI: 23.60 (+0.16)
Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016
GlobeNewswire - Wed Jul 27, 3:00PM CDT
-- Q2 revenue of $151.1 million ($151.7 million in constant currency), up 9.4% as reported, up 9.9% on a comparable, constant currency basis, over Q2 2015
MMSI: 23.60 (+0.16)
Merit Medical Announces Appointment of New Director
GlobeNewswire - Tue Jul 26, 3:00PM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy, announced today that it has appointed David M. Liu, MD, Fellow of the Royal College of Physicians of Canada (FRCPC), diplomate of the American Board of Radiology, and Fellow of the Society of Interventional Radiology (FSIR), to serve as a director of the Company.
MMSI: 23.60 (+0.16)
Dental Stock Earnings Queued Up for Jul 27: MCK, LH & More
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 7:55AM CDT
Here we take a look at four Dental stocks set to report earnings on Jul 27.
MCK: 192.09 (-2.47), CNMD: 40.17 (-0.47), LH: 139.63 (+0.07), MMSI: 23.60 (+0.16)
Merit Medical Systems to Announce Second Quarter Results on July 27, 2016
GlobeNewswire - Thu Jul 14, 8:00AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the second quarter ended June 30, 2016, after the close of the stock market on Wednesday, July 27, 2016.
MMSI: 23.60 (+0.16)
Merit Medical to Present at UBS Global Healthcare Conference
GlobeNewswire - Thu May 12, 8:00AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the UBS Global Healthcare Conference being held May 23-25 at the Grand Hyatt New York.
MMSI: 23.60 (+0.16)
Merit Medical Appointed Global Distributor for Micro Guide Wire
GlobeNewswire - Tue May 10, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has signed a distribution deal with PIOLAX Medical Devices, Inc. of Yokohama, Japan for a product known in Japan as the Labyrinth Noah(TM) Micro Guide Wire. The deal covers all global markets, with the exception of Japan, and is subject to certain minimum order requirements.
MMSI: 23.60 (+0.16)
Merit Medical meets 1Q profit forecasts
Automated Insights - Thu Apr 28, 6:44PM CDT
SOUTH JORDAN, Utah (AP) _ Merit Medical Systems Inc. (MMSI) on Thursday reported first-quarter profit of $4.4 million.
MMSI: 23.60 (+0.16)
Merit Medical Reports Sales Up 6.6% for the Quarter Ended March 31, 2016
GlobeNewswire - Thu Apr 28, 3:00PM CDT
-- Q1 revenue of $138.1 million ($140.0 million in constant currency), up 6.6% as reported, up 8.0% on a comparable, constant currency basis
MMSI: 23.60 (+0.16)
Merit Medical Systems to Announce First Quarter Results on April 28, 2016
GlobeNewswire - Mon Apr 04, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the first quarter ended March 31, 2016, after the close of the stock market on Thursday, April 28, 2016.
MMSI: 23.60 (+0.16)
Merit Medical Announces 510(k) Clearance for Corvocet(TM) Biopsy System
GlobeNewswire - Mon Mar 28, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it received notification of substantial equivalence from the FDA for the Corvocet(TM) Biopsy System, which is intended for use in obtaining core biopsy samples from the liver, kidney, prostate, breast, lung and various other soft tissue tumors.
MMSI: 23.60 (+0.16)
Merit Medical to Present at Four Conferences
GlobeNewswire - Wed Feb 10, 8:30AM CST
RBC Capital Markets - February 24
MMSI: 23.60 (+0.16)
Global Non-vascular Stents Market 2016-2020 with Boston Scientific, Cook Medical, C.R. Bard & Medtronic Dominating
M2 - Mon Feb 08, 11:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/lhzzfb/global) has announced the addition of the "Global Non-vascular Stents Market 2016-2020" report to their offering. The global non-vascular stents market to grow at a CAGR of 5.24% during the period 2016-2020. Global Non-vascular Stents Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Advances in technology have resulted in the introduction of stents in a wide range of sizes, designs, and materials. A typical gastrointestinal or urologic stent is about 18 cm. There are other micro stents available for different stent applications. The use of biodegradable polymer in non-vascular stents has the advantages of biocompatibility and eliminating the need for stent removal. According to the report, the increased incidence of gastrointestinal disorders such as colon cancer, rectal cancer, and other urological conditions, coupled with the aging population, is driving market growth. Further, the report states that complications associated with non-vascular stents restricts the market growth. To calculate the market size, the report considers the revenue generated from the sales of non-vascular stents, which are segmented as follows: - Gastrointestinal stents - Urological stents - Pulmonary stents Key vendors - Boston Scientific - Cook Medical - C.R. Bard - Medtronic Other prominent vendors - Allium Medical - EFER Endoscopy - Amecath - Applied Medical - BIOTEQ - BVM Medical - Coloplast - ConMed - ELLA-CS - EndoChoice - Hobbs Medical - Merit Endotek - Merit Medical Systems - Novatech - Olympus - Surgimedik - Taewoong Medical - Xlumena For more information visit http://www.researchandmarkets.com/research/lhzzfb/global
BSX: 24.43 (+0.15), MDT: 88.06 (+0.43), MMSI: 23.60 (+0.16)
Merit Medical Systems Down 21.8% Since SmarTrend Downtrend Call (MMSI)
Comtex SmarTrend(R) - Fri Feb 05, 6:07PM CST
SmarTrend identified a Downtrend for Merit Medical Systems (NASDAQ:MMSI) on October 23rd, 2015 at $20.09. In approximately 4 months, Merit Medical Systems has returned 21.75% as of today's recent price of $15.72.
MMSI: 23.60 (+0.16)
Merit Medical Systems to Announce Fourth Quarter and Year End Results on February 22, 2016
GlobeNewswire - Thu Feb 04, 3:00PM CST
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the fourth quarter and year ended December 31, 2015, after the close of the stock market on Monday, February 22, 2016.
MMSI: 23.60 (+0.16)
Merit Medical Acquires the HeRO(R)Graft From CryoLife, Inc.
GlobeNewswire - Thu Feb 04, 10:04AM CST
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, today announced that it has purchased the HeRO(R)Graft device and related assets from CryoLife, Inc.
CRY: 14.32 (-0.25), MMSI: 23.60 (+0.16)
